Issue 1 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

32

No.

1

January 13, 2006Jan 13, 2006

Free

DOWNLOAD THE PDF

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

NCI Faces $32 Million Budget Cut In FY 2006; NIH Tells Grantees To Expect 2.35 Percent Reduction In Award Funds.

NCI Establishes New Program Project Grant Guidelines.

Chemotherapy Pioneer Howard Skipper Dead; His Work With Lekemia Cells In Mice Led To Development of Combination Therapies.

Recent Issues

Volume 52 | Issue 34 - September 18, 2026

Volume 52 | Issue 33 - September 11, 2026

Volume 52 | Issue 32 - August 14, 2026

Volume 52 | Issue 31 - August 07, 2026

Volume 52 | Issue 30 - July 31, 2026

Volume 52 | Issue 29 - July 24, 2026